Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$8,843,636
+$1,149,928 QoQ
Shares Held
35,144
-0.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.49%
of 13F equity value
Holder Rank
#985
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NTV Asset Management LLC holds $67,135,913 across 11 Drug Manufacturers - General names. ABBV ranks #2 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,611 | $36,715,754 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
35,144 | $8,843,636 | |
| 3 | JNJ |
Johnson & Johnson
|
32,909 | $8,357,898 | |
| 4 | AMGN |
Amgen Inc
|
10,347 | $3,746,855 | |
| 5 | MRK |
Merck & Co., Inc.
|
21,525 | $2,765,962 | |
| 6 | AZN |
Astrazeneca PLC
|
13,967 | $2,648,422 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
25,439 | $1,465,795 | |
| 8 | PFE |
Pfizer Inc
|
37,616 | $905,793 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,843,636 | 35,144 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $7,693,708 | 35,375 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $8,119,849 | 35,537 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $8,324,094 | 35,951 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $6,745,987 | 36,343 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $7,622,966 | 36,383 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $6,642,959 | 37,383 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $7,468,496 | 37,819 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $6,603,691 | 38,501 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $6,956,037 | 38,199 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $5,861,430 | 37,823 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $6,415,840 | 43,042 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $5,789,617 | 42,972 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $6,865,659 | 43,080 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $6,940,503 | 42,946 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $5,747,140 | 42,822 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $6,561,068 | 42,838 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $6,970,081 | 42,996 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $5,818,679 | 42,974 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $4,762,460 | 44,150 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $4,908,851 | 43,580 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $4,721,313 | 43,627 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $4,628,772 | 43,199 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $3,761,640 | 42,946 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $4,214,081 | 42,922 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $2,977,429 | 39,079 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||